During the monitoring of a client's response to disease-modifying antirheumatic drugs (DMARDs), which findings would the nurse interpret as acceptable responses?
a) Decreased joint inflammation
b) Increased fatigue
c) Improved range of motion
d) Reduced joint tenderness
